The Campbell Analysis

A novel blood test from C2N Diagnostics, used in a major Alzheimer's trial, shows promise in predicting disease progression, heralding a new era of precision medicine.

Tech24 partners with Pacific Standard Service, a move adding deep hot-side expertise and expanding its reach in the rapidly consolidating foodservice repair market.

As media teams shrink and video demand soars, new AI tools promise to turn existing content into publish-ready videos. But can automation fill the gap?

Aderant's new AI tools promise to revolutionize lawyer performance reviews, but they also ignite critical debate on algorithmic bias and workplace ethics.

With massive revenue growth but mounting losses, Angel Studios heads to a key investor conference to prove its unique audience-led model is a new Hollywood bible.

A new AI-powered blood test for early liver cancer detection is now accessible nationwide through Quest Diagnostics, aiming to improve dismal screening rates.

Cority's new AI agents automate safety tasks, promising proactive risk prevention. But are EHS teams ready for the rapid, ungoverned adoption?

The NYC health giant is using an AI platform to find millions in savings, aiming to reinvest the money back into patient care and infrastructure.

Dave Asprey’s 2026 BEYOND conference adds star power and a focus on consciousness, but how much is science versus high-tech hype?

Overall gambling participation in Canada is declining, yet the regulated online market is booming. Who is driving this multi-billion dollar surge?

Federal banks are funding Quebec's massive Matawinie mine, a strategic move to power North America's EV industry and challenge global supply chains.

A partnership in Wichita is turning chaotic bus rides into calm journeys, using empathy and data to support students with the most complex needs.

A new exoskeleton, validated by scientific studies, shows a dramatic reduction in muscle strain and discomfort for surgeons, dentists, and industrial workers.

The firm posted a massive $66M profit, but a $77M non-cash gain and a move to OTC markets urge investors to look beyond the impressive headlines.

Patients are asking AI for medical advice. A new strategy, GEO, helps doctors stay visible and trusted in the new era of generative search results.

DIVEVOLK's latest sponsorship of a top photo contest shows how smartphones are now serious contenders for winning prestigious, professional-grade awards.

SnoFox Sciences rebrands as FieldTech and joins a national network, merging its data platform with hands-on service for a new era of industrial reliability.

As employers grapple with soaring obesity drug costs, a new partnership aims to offer predictable pricing and comprehensive care. Here's how it works.

With a $35 million boost from RA Capital, Equillium extends its cash runway to 2029, fueling the clinical development of its promising oral UC therapy, EQ504.

ProMach's strategic acquisition of Lako Tool & Manufacturing signals a major push into high-performance, sustainable flexible packaging solutions.